Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice
Davide Loizzo(University of Bari Aldo Moro), Riccardo Autorino(Cleveland Clinic), Ciro Imbimbo(University of Naples Federico II), Georgi Guruli(VCU Massey Comprehensive Cancer Center), Savio Domenico Pandolfo(University of L'Aquila), Asit K. Paul(Virginia Commonwealth University), Fabio Crocerossa(Magna Graecia University), Giuseppe Lucarelli(University of Bari Aldo Moro), Matteo Ferro(European Institute of Oncology), P. Ditonno(University of Bari Aldo Moro)
Cited by 49
Related Papers
Renal Cell Carcinoma as a Metabolic Disease: An Update on Main Pathways, Potential Biomarkers, and Therapeutic Targets
|International Journal of Molecular Sciences|2022|190
Immune Checkpoint Inhibitors in Renal Cell Carcinoma: Molecular Basis and Rationale for Their Use in Clinical Practice
|Biomedicines|2023|161
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study
|Journal of Clinical Medicine|2021|131